From: Design, pharmacokinetic profiling, and assessment of kinetic and thermodynamic stability of novel anti-Salmonella typhi imidazole analogues
Ligand
CYP45
inhibitor
ESOL
(mg/ml)
GIA
P-gp+
BBB
MUT
TUM
IR
RE
B-1
Yes
0.006
High
No
None
B-2
0.009
R
15.7